The relationships between Muscle Fibre Composition, muscle carnosine and multiple sprint (Wingate) performance by Dann, Rick
  
 
 
The Relationships between Muscle Fibre Composition, Muscle 
Carnosine and Multiple Sprint (Wingate) Performance 
Rick Alexander Dann 
Bachelor of Exercise and Sport Science (Honours) 
 
 
 
A thesis submitted for the degree of Master of Philosophy at 
The University of Queensland, School of Human Movement Studies in 2019 
 
 
 
 
 
 
 
 
 
i 
 
ABSTRACT 
Muscle Fibre Composition (MFC) and resting carnosine levels are both important 
characteristics of skeletal muscle which contribute towards performance and fatigue during 
high-intensity exercise. It’s well documented that type II fibres are fast contracting, fast 
fatiguing, and are characterised by a high metabolic capacity for anaerobic metabolism. Despite 
the ability to produce higher forces, individuals with a relatively high proportion of type II 
muscle fibres are likely to experience more acidosis within the muscle. At the cellular level, 
type II fibers also have higher resting levels of carnosine. Carnosine, a buffer of hydrogen ions, 
is therefore important in delaying the rate of fatigue during high-intensity exercise. Higher 
levels of muscle carnosine found in some athletic individuals has largely been attributed to 
genetic factors such as type II fibres, however few studies have examined this relationship. 
Therefore, the main purpose of this thesis was to examine potential relationships between MFC, 
resting carnosine levels, and multiple sprint (Wingate) performance.  
 
Twenty-six healthy males (25 ± 4 years) were recruited for this study. Each participant had a 
muscle biopsy taken from the Vastus Lateralis (VL) to determine Muscle Fibre Composition 
(MFC) and resting muscle carnosine levels. After sufficient recovery from the biopsy 
procedure, participants completed 3 x 30second sprints (Wingate bouts) on a cycle ergometer; 
each separated by 4 minutes of rest. Mean Power (MP), anaerobic capacity (AC), peak power 
(PP), total work (TW) and a fatigue index (FI) was calculated for each Wingate. The statistical 
analysis included descriptive statistics, Pearson correlation and linear regressions 
 
Resting muscle carnosine levels were not related to percentage of type II fibres (r= 0.056; p= 
0.77), percentage area of type II fibres (p= 0.83; r= 0.048) or relative fibre area (p= 0.77; r= 
0.065).  In addition, resting carnosine levels were not related to any performance or fatigue 
measures in the repeated Wingate protocol. Significant relationships were found between both 
percentage area of type II fibres (p =0.043; r = 0.04) and percentage of type II fibres (p =0.0432; 
r = 0.4075) with fatigue index during the third Wingate bout. There were no significant 
relationships between MFC and fatigue in the first Wingate, however percentage of type II 
fibres was significantly related to the fatigue profile during the last 15 seconds of the 2nd (r=-
0.42; p= 0.036) and 3rd (r= -0.44; p= 0.028) Wingate sprints. 
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In summary, resting carnosine levels were not related to MFC nor any performance measure 
from the repeated Wingate protocol. This study did show however that individuals with a 
higher percentage of type II fibres may show greater levels of fatigue and decreased 
performance in the latter stages of maximal anaerobic exercise. 
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2.0 General Introduction  
Muscle Fibre Composition (MFC) and resting carnosine levels are both important 
characteristics of skeletal muscle that contribute towards performance and fatigue during high 
intensity exercise (Begum, Cunliffe, & Leveritt, 2005; Green, 1997; Sahlin, Alvestrand, 
Bergstrom, & Hultman, 1977). Although there are various other mechanisms that contribute to 
fatigue, significant relationships between intramuscular buffer capacity, high intensity exercise 
performance and fatigue have been identified (Bell & Wenger, 1988; Nevill, Boobis, Brooks, 
& Williams, 1989). The available evidence suggests that individuals who have the capacity to 
manage and/or regulate H+ ions that are produced during intense exercise may be able to delay 
acidosis and potentially improve sprint and high intensity exercise performance.  
 
The rate at which H+ ions are produced in muscles during high intensity exercise is related to 
the type of muscle fibres recruited. When describing the physiological characteristics of muscle 
fibres, type I and II fibres each exhibit distinct metabolic and contractile characteristics. Type 
I muscle fibres produce less force but fatigue less quickly when compared to type II fibres 
(Linssen et al., 1991; Sargeant & de Haan, 2006).   
 
Bar-Or, Dotan, Inbar, and Rothstein (1980) explored the relationship between muscle fibre 
composition and fatigue profiles in a 30s sprint (Wingate test). The authors reported that 
participants who presented with a higher percentage of type II fibres also showed a significantly 
larger fatigue profile (r=0.75, p=0.001). 
 
Since the work of Bar-Or et al., (1980), investigations comparing MFC and fatigue profiles 
during high intensity exercise has been limited. Researchers have either relied on prediction 
models to determine MFC or have simply estimated MFC profiles from performance measures. 
However, Inbar, Kaiser, and Tesch (1981) used muscle biopsy samples to determine MFC and 
compared these data to various performance measures in healthy males. A key finding was that 
participants with a higher percentage of type II fibres had significantly higher peak power and 
peak torque values during a Wingate Test; fatigue data was not reported.  
 
Of the several factors that contribute to high intensity exercise and sprint performance (Bell & 
Wenger, 1988; Bishop, Edge, & Goodman, 2004; Nevill et al., 1989) muscle buffering capacity 
is particularly important. Carnosine in muscle plays a significant role in the buffering of H+ 
ions, reducing the rate of metabolic acidosis (Bishop et al., 2004; Suzuki, Ito, Mukai, 
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Takahashi, & Takamatsu, 2002). Several studies have examined the relationship between 
resting carnosine levels and fatigue resulting from high-intensity exercise (Derave et al., 2007; 
Lievens, 2017; Suzuki et al., 2002). 
 
Suzuki et al. (2002) measured resting carnosine levels from muscle biopsy samples and 
compared these with fatigue profiles from Wingate tests. Positive and significant correlations 
between resting carnosine levels, percentage of type II fibres and mean power output 
throughout the 30 seconds and last 10 seconds were found. This suggests that carnosine 
influences the fatigue profile of a Wingate test, particularly during the last 10 seconds of 
exercise. Derave et al. (2007) confirmed this relationship in their study that examined fatigue 
in response to five sets of 30 maximal voluntary isokinetic knee extensions; participants with 
higher levels of resting carnosine showed less fatigue in the latter stages of exercise.  
 
A more recent study by (Lievens, 2017) used 1H-MRS as a non-invasive predictor of MFC and 
related these data to fatigue profiles of healthy males who completed three Wingate tests in 
succession. They found that participants with higher levels of resting carnosine, as determined 
by 1H-MRS, had a higher fatigue index within each Wingate. This high fatigue index represents 
a greater reduction in power output and performance over time. They concluded that estimated 
MFC from the gastrocnemius muscle is a reliable predictor of the fatigue profile and fatigue 
index from repeated Wingate tests. 
 
Though researchers have investigated MFC, carnosine levels and fatigue profiles in separate 
studies for over thirty years (Alen, Hakkinen, & Komi, 1984; Campbell, Bonen, Kirby, & 
Belcastro, 1979; Costill et al., 1976; Kaiser, Rossner, & Karlsson, 1981), research is yet to 
examine the relationship between MFC and resting carnosine levels determined from muscle 
biopsy and fatigue profiles in response to multiple sprint exercise. Evidence by (Inbar et al., 
1981; Suzuki et al., 2002) demonstrate variance in fatigue profiles amongst individuals 
however it is still unknown whether muscle fibre composition and carnosine levels play a role 
in the rate at which individuals fatigue during high intensity exercise. The aim of this thesis is 
to extend the work of (Inbar et al., 1981; Lievens, 2017; Suzuki et al., 2002) and examine 
potential relationships between MFC, resting carnosine levels, and multiple sprint (Wingate) 
performance.  
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3.0 Literature review  
3.1 Fatigue  
A commonly accepted definition of fatigue was proposed by Edwards and colleagues, stating 
that ‘fatigue is failure to maintain the required or expected force (or power output)’ (1983). 
Fatigue experienced by athletes occurs as a result of impaired muscle function and/or a 
decrease in cognitive performance (R. H. T. Edwards, Porter, & Whelan, 2009), Irrespective 
of the origin, fatigue during exercise results in a decline in performance (Derman, Hawarden, 
& Schwellnus, 2010). 
3.1.1 Mechanisms of Fatigue: 
During high intensity exercise, a reduction in Adenosine TriPhosphate (ATP), Phosphocreatine 
(PCr) and glycogen, and the accumulation of Adeonosine DiPhosphate (ADP), Phosphate (P) 
and Hydrogen (H+) irons are believed to each contribute to fatigue  (Begum et al., 2005; Green, 
1997; Sahlin et al., 1977). The contribution of H+ ions to fatigue is undecided, however their 
accumulation results in a fall in intramuscular pH; the rate and extent of metabolic acidosis 
(Juel, 1997; Parkhouse & McKenzie, 1984) is related to fatigue and performance during high 
intensity exercise performance (Bell & Wenger, 1988; Nevill et al., 1989). Therefore, 
individuals who are able to regulate H+ ions or simply produce less of them during high 
intensity exercise will potentially present with smaller and less severe fatigue profiles during 
‘all-out’ anaerobic sprint exercise.   
3.2 Muscle Fibre Composition and Fatigue   
Cell size in addition to the sarcoplasmic reticulum, capillary density, oxidative capacity and 
type of myosin ATPase vary between skeletal muscle fibre types; these differences are 
collectively responsible for differences in function between fibres (Cormie, McGuigan, & 
Newton, 2011; Scott, Stevens, & Binder–Macleod, 2001; Robert S. Staron, 1997). Type II 
skeletal muscle fibres are faster to contract and produce greater force compared to type I fibres.  
However, type II fibres fatigue faster during high intensity exercise (Linssen et al., 1991; 
Sargeant & de Haan, 2006). Compared to type I fibres, type II fibres have a greater capacity 
for anaerobic metabolism (Karlsson, Sjodin, Jacobs, & Kaiser, 1981) and differ in H+ ion 
production and handling, sodium/potassium pump function, ATPase activity and calcium 
resorption/handling by the sarcoplasmic reticulum (Allen, Lamb, & Westerblad, 2008; Fitts, 
1994; Green, 1997; Karlsson et al., 1981).  
 15 
 
 
One of the first studies to examine a potential relationship between muscle fibre composition 
and high intensity exercise performance was conducted by Bar-Or et al. (1980). They 
determined MFC from a biopsy taken from the Vastus Lateralis (VL) and used a single Wingate 
test (30s cycle sprint) to assess performance and fatigue. Changes in power output were 
compared with the percentage of type II fibres and fibre cross sectional area. Participants with 
a higher percentage of type II fibres showed higher average power (r=0.63, p=0.0; n=19) and 
larger fatigue profiles (r=0.75, p=0.001; n=19).  
 
Thorstensson and Karlsson (1976) also investigated the relationship between fatigue and 
muscle fibre type. Muscle fibre composition of the VL muscle was determined from muscle 
biopsies in ten healthy male subjects between 25 and 40 years of age. Fatigue was measured 
by a reduction in force production during the repeat isokinetic knee extension protocol. A linear 
relationship was found between fatigue and the percent of type II muscle fibres (r= 0.86, p= 
<0.01; n=10). 
3.2.1 Muscle Fibre Composition and Performance  
Various investigations (Douris et al., 2006; Foster, Costill, Daniels, & Fink, 1978; Fry et al., 
2003; Inbar et al., 1981; Methenitis et al., 2016) have shown that muscle fibre composition is 
a significant determinant of performance across a variety of different exercise tasks. Muscle 
fibre type influences aerobic (Foster et al., 1978), strength (Douris et al., 2006; Inbar et al., 
1981), and power (Fry et al., 2003; Methenitis et al., 2016) performance. 
 
Inbar et al. (1981) examined the relationship between muscle fibre composition in both aerobic 
and anaerobic performance capacities. Twenty-nine healthy males [8 sedentary, 5 physically 
active, 16 trained runners (7 long-distance and 9 short distance)] completed a Wingate test (30s 
cycle sprint), an isokinetic single leg test, a 40 metre sprint, a 300 metre run and a 2000 metre 
run. Muscle was biopsied from the VL muscle and fibre composition was determined. Peak 
power and maximal peak torque during the Wingate test were significantly (p < 0.001) related 
to type II fibre percentage. Significant relationships were also found between the percentage of 
type II muscle fibre and 40m sprint and 2000m performances (positive and negative 
relationships respectively). The authors concluded that muscle fibre composition influenced 
performance of both short term and endurance based exercises. 
 16 
 
 
An investigation by Fry et al. (2003) compared muscle fibre characteristics and composition 
with performance in male Olympic weightlifters.  Muscle was biopsied from the VL muscle of 
six highly trained weightlifters. The ‘snatch’ movement and countermovement jump were used 
as measures of power whilst the clean and jerk was used as a strength dominant exercise. The 
weightlifters (n=7) possessed a larger percentage of type II fibers compared to the untrained 
group (n=7). The weightlifting and vertical jump performances in the trained group were 
related to the estimated number of their type IIa fibres. Performance in the snatch and vertical 
jump was positively related to the estimated number of type IIa fibres whilst the clean and jerk 
performance correlated with a smaller area of IIb fibres. The authors suggested that the 
proportions of type IIa and IIb fibres were the dominant factors relating to performance in the 
clean & jerk, snatch and countermovement jump performance of trained men. 
 
A more recent investigation by Methenitis et al. (2016) examined the relationships between 
conduction velocity, muscle fibre composition and power performance in subjects with 
different training backgrounds. Subjects were assigned to one of four groups; sedentary (n=10), 
endurance athletes (n=9), power trained (n=10) and strength trained (n=9). The power trained 
athletes performed significantly better in a countermovement jump test and had a significantly 
higher rate of force development and percentage of cross section area of type II fibres than the 
other groups (P < 0.001). It was concluded that the neural signal patterns and the size and 
percentage of type II fibres present in the VL contributed towards performance in multi-joint 
explosive movements.  
 
Muscle fibre typology is clearly related to different performance measures. Type II fibres in 
particular have been consistently related to performance increases in powerful movements such 
as sprinting and countermovement jumps. There is limited research however of the importance 
of type I fibres and their contribution towards similar exercise testing. Whether a relationship 
exists between muscle fibre type (and muscle carnosine levels) and performance in physical 
tests that assess muscular strength, power and endurance, is yet to be determined. 
3.3 Determining Muscle Fibre Composition 
Skeletal muscle tissue has been examined in clinical and experimental populations since the 
1860’s (Costill et al., 1976).  Early researchers sampled muscle post mortem; an advantage of 
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this being that large samples could be examined. The first biopsy procedure conducted on a 
living subject was performed by the French Neurologist, Guillaume-Benjamin-Amand 
Duchenne (Patel, Cooper, & Aihie Sayer, 2012). Duchenne’s original method was refined by 
others and the procedure became safer and more effective (O'Rourke & Ike, 1995).  
 
There have been many different variations in the needle biopsy but the use of percutaneous 
needles has been strongly favoured over the open biopsy method. Percutaneous biopsy needles 
leave smaller scars, are relatively cheap to use and different parts and depths of the muscle 
belly can be sampled (R. Edwards, Young, & Wiles, 1980; O'Rourke & Ike, 1995). In 1962 
Jonas Bergstrom introduced his version of a percutaneous biopsy needle and this revolutionised 
the way skeletal muscle tissue is extracted (Bergstrom, 1975). The Bergstrom needle consists 
of a sharp trocar, cutting cannula and a pushing rod which extracts between 25-75 mg of muscle 
tissue. The introduction of this needle allowed scientists to examine changes in muscle 
metabolites in response to acute and chronic exercise for the first time. Determination of fibre 
type composition (i.e., numbers and sizes of slow and fast contracting fibres) was also possible. 
Fibre typology involves taking a sample of muscle tissue then trimming the sample for the 
cross sectional area to be exposed for analysis. The tissue sample is then stained for myofibrillar 
ATPase which differentiates slow (type I) and fast (type II) contracting fibres (Donselaar, 
Eerbeek, Kernell, & Verhey, 1987; Meunier, Picard, Astruc, & Labas, 2010).  
 
Since the introduction of the Bergstrom needle, numerous investigators have made adjustments 
to maximise the size of muscle sampled and reduce discomfort for the subject. Variations have 
included the use of suction (Hennessey, Chromiak, Della Ventura, Guertin, & MacLean, 1997) 
which was first established in 1982 and has been shown to increase tissue yield between two-
to-five fold whilst ensuring trauma to the subject remains minimal (Evans, Phinney, & Young, 
1982).  
 
Gollnick, Armstrong, Saubert, Piehl, and Saltin (1972) were the first to investigate the enzyme 
activity and fibre composition of healthy, trained and untrained men using the biopsy samples. 
They found that the endurance trained athletes had a significantly higher percentage of type I 
fibres (60%) compared to the non-trained participants (44%). The oxidative capacity of both 
type I and II muscle fibres present in the endurance athletes also showed a higher oxidative 
capacity than the untrained participants. Prince, Hikida, and Hagerman (1976) also reported 
that elite distance runners had a higher percentage of type I fibres and fewer type II fibres 
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compared to the untrained participants and power athletes. They reported that the endurance 
group possessed on average 83% type I fibres compared to 55% in the power lifter group. This 
difference in percentage was consistent with the findings of Costill and colleagues; their 
endurance (long distance) runners had on average 69.4 ± 4.8% type I fibres compared to 
sprinters who had 27.4 ± 3.2%. Both of these research groups sampled muscle from the VL 
muscle and determined muscle fibre type composition from myosin ATPase activity.  
 
Tesch, Thorsson, and Kaiser (1984) examined potential differences in capillary supply and 
fibre type characteristics between elite power lifters, endurance athletes and non-athletes. The 
percentage of type II fibres for power lifters was 70 ± 6%, while for endurance athletes it was 
40 ± 11% and for non-athletes it was 61 ± 10%. Ricoy, Encinas, Cabello, Madero, and Arenas 
(1998) have since shown that sprinters and power-lifters also possesses higher percentages of 
type II fibres. Their investigation reported the histochemical data of VL muscle of 16 women 
and 66 men (72 of whom were athletes in various events). They also determined that the largest 
percentage of type I fibres was present in long distance runners.  In contrast to elite power and 
endurance athletes, the muscle fibre composition of healthy (untrained) individuals is usually 
close to 50% type I and 50% type II  (Elder, Bradbury, & Roberts, 1982; Gollnick et al., 1973; 
Howald, Hoppeler, Claassen, Mathieu, & Straub, 1985; E. Jansson, Sjodin, & Tesch, 1978; 
Johnson, Polgar, Weightman, & Appleton, 1973). 
3.3.1 Assessing muscle fibre type from Biopsy Samples 
Although the percutaneous needle biopsy technique is relatively simple and cheap, it is 
invasive. There is the possibility of formation of scare tissue around the wound and a degree 
of discomfort and risk, albeit small, of nerve damage and internal localised bleeding. While 
recovery time following the procedure is generally acceptable with recreationally active 
individuals, it is less suitable for use in athletic populations. Due to these collective limitations, 
the use of muscle biopsies is not generally welcomed by athletes and support/coaching staff of 
athletic populations.  
 
In addition to the above mentioned limitations, there is evidence that the percentage of type I 
and II fibres may vary at different depths within the muscle belly (Elder et al., 1982; Jennekens, 
Tomlinson, & Walton, 1971). Therefore, muscle sampled using the needle biopsy technique 
may not provide an accurate representation of an individual’s whole-muscle fibre composition. 
 19 
 
3.3.2 MFC Variability and Morphology   
Studies that have examined differences in skeletal muscle fibre composition between 
individuals have generally biopsied muscle from the gastrocnemius or VL. These muscles have 
more of a ‘mixed muscle fibre composition’ profile compared to other muscles. Other muscles 
such as the triceps which is predominantly comprised of type II fibres (67.3%) or the soleus, 
which is predominantly comprised of type I fibres (68%) show less variation between 
individuals (Elder et al., 1982; Gollnick et al., 1972; Johnson et al., 1973).  
A number of studies from the 1970s have examined whether the metabolic and/or contractile 
characteristics of skeletal muscle respond to training. Gollnick et al. (1972) investigated 
enzyme activity and fibre composition of 74 healthy men; muscle was biopsied from the deltoid 
and VL muscles. The subject population varied from untrained to trained athletes in various 
different sports (swimmers, runners, weightlifters, canoers and cyclist). The authors reported 
the untrained group averaged 46% type I muscle fibres and 57% type II in the deltoid muscle.  
Despite the average composition being approximately neutral (51.5%), the range of this 
groups’ composition varied from possessing 14 – 60% type I muscle fibers. A similar trend 
was also found after examining the VL muscle. The young and middle aged participants 
combined presented with an average of 40% type I muscle fibres. In comparison to the 
untrained group, the endurance based athletes had on average a significantly higher percentage 
of type I fibres (72.5%).  
One year after Gollnick and colleagues released their findings, Johnson et al. (1973) published 
an article which examined the muscle fibre type composition in 36 different human muscles.  
Six male autopsy subjects aged between 17 and 30 years old were investigated. Muscle fibre 
type was determined from 50 sites across 36 different muscles in each subject. There was a 
wide variation in fibre type composition in the majority of muscles across subjects. In 41 of 
the 50 sites, there was a significant difference in composition between each subject. A notable 
finding was that tonic muscles (iliopsoas and erector spinae) had a relatively high percentage 
of type I fibres while phasic muscles (gluteus maximus, biceps femoris and rectus femoris) had 
a high percentage of type II fibres. Muscles such as soleus and tibialis anterior which are 
predominantly postural muscles had on average 87% and 73% type I fibres respectively. 
Adductor Pollicis had a significantly high percentage of type I fibres (80%) which could be 
possibly explained by the contribution of this muscle in isometric grip strength involved in 
many day-to-day activities. This premise was also consistent with muscles which are 
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predominantly phasic in nature. Orbicularis Oculi (84.6%), sternocleidomastoid (64.8%), 
triceps brachii (67.5%) and rectus femoris (70%) were all identified as muscles with the highest 
percentage of type II fibres. Their primary functions include blinking, head movements, 
extension of elbow and flexion of knee respectively.  
3.3.3 Different Classifications of Fibres  
There are different ways of classifying muscle fibres from biopsy samples.   While researchers 
have generally classified samples as being ‘type I and II’, some have employed a more detailed 
histochemical classification: type I, IC, IIC, IIAC, IIA, IIAB and IIB (Scott:2001, 
Meunier:2010). R. S. Staron et al. (2000) also used the same ‘6 category’ approach for 
classification and presented muscle fibre data collected over a ten year period. Their findings 
highlighted a gender difference when examining area occupied by each of these specific fibre 
types. Men presented with IIA>I>IIB whilst women possessed I>IIA>IIB. A staining process 
was used for the identification of each fibre type. Scott et al. (2001) explain how histochemical 
staining can result in a more accurate and precise analysis of myosin ATPase. By identifying 
the different intensity of staining, the characteristics of muscle cells can be further understood 
and therefore more accurate representation of the muscle fibre type composition can be made. 
However, the majority of the current literature uses three classifications of muscle fibre type 
(type I, IIa, IIb) which is considered to be sufficient in the classification of fibre type.  
3.3.4 Contractile and Metabolic Characteristics  
The variability in contractile characteristics of muscle is largely genetically determined, and 
there is little influence from training (Komi et al., 1977; Simoneau & Bouchard, 1989; 
Simoneau et al., 1986). Simoneau and Bouchard (1989) investigated the influence of genetics 
on determining an individual’s fibre composition compared to other external factors. This 
investigation examined the muscle fibre composition of 418 biopsies taken from the VL muscle 
of 270 healthy sedentary and 148 physically active participants. Overall, 15% of the total 
variance in fibre composition in humans was due to sampling and technical error, 40% due to 
environmental factors and the remaining 45% due to genetics alone.  
Komi et al. (1977) also examined genetic influence on fibre composition and conducted an 
investigation aimed at exploring skeletal muscle fibre composition and muscle enzyme activity 
in monozygous and dizygous male and female twins. Muscle was sampled from the VL muscle 
from 31 pairs of twins. When comparing both types of twins and both sexes, each exhibited a 
 21 
 
similar muscle fibre type composition. This particular investigation concluded that genetics is 
the predominant influence on muscle fibre type composition. A separate twin study by 
Bouchard and colleagues (1986) compared non-twin brothers (n=32), dizygotic (n=26) and 
monozygotic (n=35) twins to examine the genetic effect on muscle fibre type composition.  
Biopsies from the VL were taken which showed that the genetic effect contributes to around 
25% – 50% of the total muscle fibre type composition variation after being adjusted for age 
and sex differences.  
Although there is strong evidence to suggest genetics plays a leading role in determining the 
contractile characteristics of muscle fibres, a muscle fibre’s metabolic characteristics are highly 
responsive to training (Holloszy & Coyle, 1984; Howald et al., 1985; Eva Jansson, Sjödin, & 
Tesch, 1978; Trappe, Costill, & Thomas, 2001). Some have taken the nurture approach and 
suggest there is reason to believe that training or exercise interventions play a role in 
determining muscle fibre composition. Endurance training can result in significant adaptations 
to skeletal muscle tissue and the respective muscle fibres (Holloszy & Coyle, 1984). This 
review of the literature suggests that there is a common increase in mitochondrial content and 
oxidative capacity of type I and IIa muscle fibres after endurance training. Additionally, there 
has been a greater dependence on fat oxidisation, slower use of muscle glycogen and less lactate 
production as a result of endurance training. While these changes are metabolic in nature, the 
contractile characteristics of each muscle fibre type stays relatively stable in response to 
training. Howald et al. (1985) examined changes in metabolic characteristics in muscle fibres 
with endurance training in 10 sedentary previously sedentary subjects. The six week 
intervention consisted of 30 minute sessions on cycle ergometers, five times a week. The 
muscle fibre types were identified using metabolic enzyme activity. Both fibre types showed 
significant metabolic changes with a 12% increase (type I) and 24% reduction (type IIb) in 
oxidative capacity. The investigators concluded that high intensity endurance training 
promotes development of the oxidative capacity (in particular, the mitochondrial activity) in 
both fibre types in untrained males. There were no contractile fibre characteristics examined in 
the methods of this study.  
Despite this clear change in metabolic properties of fibres in response to training, various 
investigators have shown that the contractile characteristics are less responsive to a training 
intervention (Andersen & Aagaard, 2006; Zierath & Hawley, 2004). Time to peak tension, 
𝐶𝑎2+myosin ATPase and 𝑚𝑔2+ actomyosin ATPase have been examined in both type I and II 
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muscle fibres with only subtle changes detected after training. A study by Trappe et al. (2001) 
examined the effects of a 21 day reduction in training volume (taper) on muscle function and 
muscle fibre type. The authors examined metabolic enzyme activity to determine muscle fibre 
type whilst also examining changes in contractile characteristics such as force production. Both 
type I and type II fibres were examined from muscle biopsies of six young (20 ± 1 years) 
college swimmers throughout the duration of a tapering period. Type IIa fibres had a much 
greater response to tapering after 6 months of high volume swim training. A significant 
difference (0.63Mn ± 0.04 – 0.82± 0.05) was also found in the peak force production of the 
type IIa fibres post- swim taper. It was proposed that these findings were due to the increase in 
size (diameter 11%) of the IIa muscle fibres. Although the changes in contractile characteristics 
were minimal in this study, the authors concluded that there is still some changes due to an 
exercise or lack of exercise stimulus, especially towards type IIa fibres (Trappe et al., 2001). 
Therefore, there may be a shift in contractile characteristics between types IIa and IIb but not 
between I and II.  
 
In summary, studies have shown muscle fibre composition is mostly genetically determined, 
with a possibility of subtle and minimal changes from intense training bouts or exercise 
interventions. While metabolic characteristics of fibres can change with different training 
backgrounds and interventions, the contractile speeds of type I and type II muscle fibres remain 
unchanged with training. There is evidence of contractile changes between subdivisions of the 
type II fibres (type IIa and IIb) but not between types I and II.  
3.4 Muscle Carnosine and Fatigue  
Muscle carnosine influences buffering capacity and has thus been identified as significant 
contributor to high intensity exercise performance and fatigue (Bell & Wenger, 1988; Bishop 
et al., 2004; Nevill et al., 1989; Suzuki et al., 2002). A number of studies have examined the 
relationship between resting carnosine levels and fatigue during high-intensity exercise 
(Derave et al., 2007; Lievens, 2017; Suzuki et al., 2002). 
3.4.1 Carnosine and Wingate-induced Fatigue 
Suzuki et al. (2002) examined relationships between muscle carnosine, fibre composition and 
high-intensity exercise performance (2002). It is important to note that the muscle carnosine 
values and muscle fibre composition were both estimated from the VL muscle using needle 
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biopsy. Muscle data were compared with peak power, mean power and fatigue derived from a 
Wingate cycle test. The authors found a significant correlation (r=0.65, p<0.05; n=11) between 
resting carnosine levels and the percentage of type IIx fibres. There also was a significant 
correlation between carnosine levels and mean power (r=0.79, p<0.01; n=11) and also between 
carnosine levels and power output over the final 10 seconds of the sprint (r=0.66, p<0.05; 
n=11). It was concluded that resting carnosine values were related to Wingate test performance 
and fatigue.  
 
A study by Derave et al. (2007) found similar results when the effects of beta-alanine 
supplementation on isokinetic and isometric fatigue were examined. Beta alanine 
supplementation has been shown to increase resting levels of muscle carnosine concentrations.  
The authors’ protocol required participants to complete five sets of 30 maximal voluntary 
isokinetic knee extensions at 180 degrees. Participants who had higher levels of carnosine due 
to Beta alanine supplementation performed better (p=0.05) in the latter stages of the test. These 
results support Suzuki’s findings and indicate that carnosine loading may significantly improve 
the latter stages of high-intensity exercise. 
 
A recent investigation by Lievens (2017) examined the relationship between percentage of type 
II fibres and fatigue during a Wingate test. Twenty-one healthy males had their gastrocnemius 
MFC assessed using 1H-MRS. Six participants presented with mainly Type II fibres whilst six 
were mainly Type I. These 12 participants then performed three Wingate tests, each separated 
by four minutes of passive recovery. Peak power, average power and fatigue index were 
calculated for each sprint. It was found that the type II dominant group had on average a higher 
fatigue index within each Wingate test and for the three combined tests. The mean power 
however did not change between groups. It was concluded that despite the consistency of mean 
power, there were significant relationships between muscle fibre composition, the fatigue 
profile and the fatigue index from repeated Wingate sprints. 
3.5 Muscle Carnosine 
3.5.1 Carnosine in type II fibres  
Muscle carnosine is a dipeptide typically found in high concentrations in type II muscle fibres 
(Blancquaert, Everaert, & Derave, 2015; Harris, Dunnett, & Greenhaff, 1998; Harris et al., 
2006). Although the main physiological roles of carnosine are not completely clear, researchers 
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have identified it as a pH buffer in skeletal muscle (Mannion, Jakeman, Dunnett, Harris, & 
Willan, 1992; Smith, 1938). Harris et al. (1998) were the first to identify a relationship between 
carnosine and type II fibres. They took muscle biopsies from the VL muscle with four 
participants. ATP-ase activity (to determine muscle fibre type) and carnosine were measured. 
On average, type II muscle fibres had more than twice as much carnosine (23.3mM) than type 
I fibres (10.5mM). Research in the field since the work of (Harris et al., 1998) has consistently 
shown that type II fibres in inactive, active and athletic populations all have around two-fold 
carnosine content than type I fibres.  
3.5.2 Dietary effects on resting carnosine levels  
Given that the best dietary sources of carnosine are meat, a number of studies have examined 
the relationship between dietary behaviours and resting carnosine levels. Baguet, Everaert, De 
Naeyer, et al. (2011) reported a vegetarian diet resulted in significantly lower resting muscle 
carnosine levels. 1H-MRS was used to estimate carnosine concentrations in 149 healthy 
participants (94 men and 55 women); levels in the soleus, gastrocnemius and tibialis anterior 
muscles were recorded and dietary records analysed. Amongst the 94 men, there were 15 
vegetarians who had a 26% lower carnosine level in the gastrocnemius when compared to the 
rest of the men.  
 
Various investigators (Derave et al., 2007; Harris et al., 2006; Hill et al., 2007) have examined 
the influence of beta-alanine supplementation on resting carnosine levels. Harris et al. (2006) 
supplemented participants over four weeks with 3.2 g.d and 6.4 g.d of beta-alanine and found 
42.1 and 64.2% increases in resting carnosine levels respectively. Derave et al. (2007) 
conducted a placebo- controlled, double blind study to examine changes in muscle carnosine 
concentrations in sprint athletes (n=15) over four weeks of beta-alanine supplementation. 
Carnosine levels were measured using proton MRS before and after the supplementation 
period. After four weeks, the beta-alanine group increased their carnosine levels in the 
gastrocnemius and soleus by 37% and 47% respectively. Hill et al. (2007) examined thirteen 
individuals who also followed a beta-alanine supplementation program and twelve individuals 
who received a placebo condition for up to 10 weeks. Muscle biopsies from the VL were 
analysed for carnosine; carnosine levels significantly increased by 58% and 80% after four and 
10 weeks respectively in the beta-alanine supplementation group. There were no increases in 
carnosine levels in the control group. 
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In their paper that reviewed the determinants of muscle carnosine content, (Harris et al., 2012) 
concluded that muscle fibre type, species, beta-alanine intake and training all influence resting 
carnosine levels. Consistent with this, a number of studies (Parkhouse, McKenzie, Hochachka, 
& Ovalle, 1985; Tallon, Harris, Boobis, Fallowfield, & Wise, 2005) have found that resistance 
trained individuals have higher than average muscle carnosine levels.   
 
Baguet et al. (2009) identified carnosine as a relatively stable metabolite within skeletal muscle 
after examining the washout of beta-alanine and carnosine following a period of beta-alanine 
supplementation. Fifteen untrained males were assigned either to a supplementation or placebo 
group for 6 weeks. In this investigation, the control group (5.9± 0.9) only experienced a 9-15% 
change in muscle carnosine levels over a 3 month wash-out period. The authors suggested this 
amount of variability is small and that these results indicate that carnosine is a stable molecule 
(Baguet et al., 2009). However, it is important to consider the limitations of using carnosine 
concentrations to estimate muscle fibre composition. To elicit the same changes in carnosine 
concentrations through the diet, 4kg of red meat or 1.2kg of turkey meat would need to be 
consumed daily (Wolos, Piekarska, Pilecka, Ciereszko, & Jablonowska, 1983).  Thus, diet 
alone is not likely going to change carnosine levels to the same extent of beta-alanine 
supplementation.  
 
The collective weight of available evidence suggests that carnosine levels differ between 
populations with different training practices.  However, a number of factors (eg., muscle fibre 
composition, dietary intake of meat, beta-alanine supplementation) will also influence these 
levels to varying degrees. 
3.5.3 Training Effects on Resting Muscle Carnosine Levels  
A number of investigations have examined the influence of training on muscle carnosine levels.  
Most studies suggest there is no significant change in muscle carnosine concentrations in 
response to training. Kendrick et al. (2008) and Mannion, Jakeman, and Willan (1994) used 
sprint training in their interventions which took place over 4-16 weeks. Kendrick et al. (2008) 
prescribed whole-body training and cycle training in two different studies. The first training 
intervention consisted of resistance training 4 days/week for 10 weeks (n=26). The four 
sessions each week were divided into 2 x upper body and 2 x lower body with the aim of 
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increasing whole-body strength and overall muscle mass. After 10 weeks of resistance training, 
there was no change (29.2 mM +- 9.8 mM – 27.3 mM +- 9.5mM) in muscle carnosine levels. 
 
Mannion et al. (1994) had three groups complete isokinetic knee extension 3 days/week for 16 
weeks. Group 1 (n=13) performed the knee extensions at 4.19 rad.s-1 for six sets of 25 
repetitions with 30 seconds rest, Group 2 (n=10) performed the knee extensions at 1.05rad.s-1 
for six sets of 15 repetitions with 40 seconds rest and Group 3 (control group; n=10) did not 
perform any knee extensions. Despite an increase in work capacity after the 16 weeks of 
training, there was no significant change (p=0.37) in muscle carnosine levels assessed through 
muscle biopsy tissue samples.  
 
A recent investigation by Baguet, Everaert, De Naeyer, et al. (2011) examined potential 
changes in muscle carnosine levels in response to a training intervention with participants 
following either a mixed or a vegetarian diet. The subjects completed 2-3 sessions of sprint 
training each week for five weeks. No significant increases in muscle carnosine were found for 
the training and mixed diet group and no changes were found between the training and 
vegetarian diet group. Muscle carnosine was measured by 1H-MRS pre- and post-exercise 
intervention.  
 
Although the majority of the current literature shows that skeletal muscle carnosine 
concentrations remain unchanged in response to training, an investigation by (Y. Suzuki, Ito, 
Takahashi, & Takamatsu, 2004) found that sprint training increased carnosine levels (measured 
using muscle biopsies), in athletic individuals. The exercise intervention involved a total of 28 
Wingate tests over the entire duration of the study. The authors observed a doubling of muscle 
carnosine levels in six participants. It is worth noting that one participant’s baseline carnosine 
concentration was 3.4 mmol.kg-1 and this increased to 13.6mmol.kg-1 after the training 
intervention. Limitations of this study include the low number of participants (n=6) and a low 
total duration (14 minutes) of training. It is questionable that such a low training volume can 
produce an increase in resting carnosine levels as reported; others have not shown similar 
findings.  
 
A recent study by Painelli et al. (2018) investigated the effects of high-intensity interval 
training on resting muscle carnosine levels. Resting muscle carnosine levels were determined 
through chromatography on 20 recreationally active males. The HIIT group (n=10) performed 
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HIIT training on a cycle ergometer 3 days a week for 12 weeks.  The HIIT group followed a 
progressive protocol which started as six bouts of 2 minute sprints (140% of lactate threshold) 
in week 1 and progressed to 12 bouts (170% of lactate threshold) in week 12. Muscle carnosine 
levels increased in both type I (from 14.4 ± 5.9 to 16.8 ± 7.6; p= 0.047) and II fibres (from 18.8 
± 6.1 to 20.5 ± 6.4; p= 0.067) for the HIIT group. This suggests there is potential for an increase 
in resting carnosine with 12 weeks of HIIT training.  
 
In conclusion, MFC, resting carnosine levels and fatigue profiles have been examined in a 
number of studies for over 30 years (Alen et al., 1984; Campbell et al., 1979; Costill et al., 
1976; Kaiser et al., 1981). However, investigations that have explored the relationships 
between them have generally been limited to MFC prediction methods. Evidence by (Inbar et 
al., 1981; Suzuki et al., 2002) demonstrate variance in Wingate-induced fatigue profiles 
amongst individuals, however it is still unknown whether MFC and carnosine play a significant 
role in the way an individual fatigues during high intensity exercise. Therefore, the aim of this 
thesis is to examine the potential relationships between MFC, resting carnosine levels and 
multiple sprint (Wingate) performance. 
 
It is hypothesised that percentage of type II fibres will have a positive relationship with resting 
muscle carnosine levels and repeated sprint performance. The secondary hypothesis is that 
participants with higher carnosine levels will perform better (fatigue less) in the latter stages of 
a 30-second sprint whilst also in the subsequent 2nd and 3rd Wingate tests. 
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4.0 The Relationship between Muscle Fibre Composition, Muscle Carnosine and Multiple 
Sprint (Wingate) Performance 
4.1 Introduction 
While a number of mechanisms influence performance during high intensity exercise, acidosis 
resulting from an accumulation of hydrogen ions has long been implicated in the fatigue 
process (Juel, 1997; Parkhouse & McKenzie, 1984).  In turn, muscle fibre composition and 
resting carnosine levels have consistently been related to both the production and buffering of 
hydrogen ions respectively (Bell & Wenger, 1988; Parkhouse et al., 1985).  
 
Compared to type I skeletal muscle fibres, type II fibres are fast contracting and fast fatiguing; 
they are also characterised by a high metabolic capacity for anaerobic metabolism 
(Staron:1997, Scott:2001, Cormie:2011).  Thus, individuals with a high relative proportion of 
type II muscle fibres generate higher forces, more rapidly.  However, in producing more energy 
through anaerobic metabolism to achieve these higher forces, there is likely more rapid acidosis 
within the muscle.  
 
Type II skeletal muscle fibres have higher resting levels of carnosine than type I skeletal muscle 
fibres (Harris et al., 1998).  Carnosine is a buffer of hydrogen ions and is thus a factor identified 
by researchers as being important in delaying the rate of fatigue during high intensity exercise.  
Indeed, sprinters are characterised by higher resting levels of carnosine and this has been 
attributed to genetic factors (eg. a higher % of type II fibres) in addition to potential adaptations 
resulting from training (Baguet, Everaert, Hespel, et al., 2011).  Diet and supplementation with 
beta alanine have also been shown to influence resting muscle carnosine concentrations. 
 
In addition to those studies that have shown a positive and significant relationship between 
type II muscle fibres and resting carnosine concentrations, other investigations have shown a 
relationship between carnosine concentrations and high intensity exercise performance 
(Lievens, 2017; Suzuki et al., 2002).  However, few studies have examined the relationship 
between muscle fibre type, muscle carnosine concentrations derived from muscle biopsies and 
Wingate-induced fatigue with the same cohort of participants. The aim of this study was to 
extend the recent work of (Inbar et al., 1981; Lievens, 2017; Suzuki et al., 2002) to better 
describe the relationships between MFC, resting carnosine levels and Wingate-induced fatigue 
using a large heterogeneous group of trained males. Exploring these relationships may provide 
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valuable information for prescribing training interventions for Type I or II predominant 
individuals, whilst also providing evidence for athletes currently supplementing with β-
Alanine. 
4.2 Methods  
4.2.1 Participants 
Thirty (n=30) healthy males (25 ± 4 years) were recruited for this study. The primary exclusion 
criteria were vegetarians and/or those who had supplemented with beta-alanine in the previous 
three months. The study was approved by an ethics committee at The University of Queensland 
(AN: 2019001335).  
Table 1. Participant Characteristics  
No. of 
Participants 
Age (years) Height (m) Body Mass (kg) 
30 25 ± 4  1.75 ± 0.11 74.0 ± 9.8 
 Mean ± standard deviation. 
4.2.2 Recruitment 
Participants were recruited from the student population, local rugby league clubs, triathlon 
squads, rowing clubs and a high performance academy. 
 
4.3 Experimental Overview 
The study required each participant to attend one muscle biopsy session and complete one 
Wingate testing session. An Adult Pre-Exercise Screening (APSS) Form was sent to each 
participant prior to confirming their place in the study. Participants were stratified as ‘Low 
Risk’ to ensure they were safe to conduct the high intensity session. Each underwent the muscle 
biopsy procedure in their first session; muscle was sampled from the right VL. Muscle tissue 
was cleaned, prepared for its respective analysis and then placed directly in a freezer. A total 
of 30 participants completed the biopsy procedure. Participants were asked to refrain from 
strenuous and moderate intensity exercise for 24 hours prior to the Wingate session. The 
Wingate session comprised of a standardised warm-up of low intensity cycling and dynamic 
stretches. Three x 30 second cycle sprints were then completed, with each sprint separated by 
4 minutes of rest. Of the 30 participants who completed the biopsy procedure, three were unable 
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to complete the Wingate session due to injury. Twenty-six of the 27 participants were able to 
complete the full repeat Wingate protocol, with one reporting light-headedness and nausea after 
the second Wingate. Thus, 26 participants completed the full study protocol.    
4.4 Muscle Biopsy Session  
4.4.1 Pre- Muscle Biopsy 
Prior to muscle sampling, each participant was provided with a ‘Biopsy Information Sheet’ and 
‘Biopsy Care Form’ for detailed explanation of all safety considerations associated with the 
procedure. Participants were asked to avoid vigorous exercise involving the legs for 48 hours 
prior to the biopsy session.  
4.4.2 Muscle Biopsy Procedure  
Each participant had muscle sampled from the VL muscle in the right thigh using a sterile 
hollow needle. The whole insertion region on the thigh was carefully cleaned before a small 
amount of local anaesthetic was injected under the skin (5-10mL of 10mg.mL Xylocaine).  A 
small ~10 mm incision was made into the skin and underlying fascia to create an opening for 
the biopsy needle. The biopsy needle was then inserted through the incision into the muscle 
belly of the VL muscle and a small piece of muscle (~200 mg) was removed. The needle was 
then immediately removed. Following the biopsy, the incision was closed with sterile tape 
(steri-strips) and wrapped with a tensor bandage.  
4.4.3 Biopsy Sample Storage 
In preparation of the Immunohistochemical analysis (fibre typology), each sample was quickly 
washed in 0.9% saline before any fat, connective tissue or blood was removed. The sample was 
then weighed and frozen in Isopentane before being cooled on dry ice. Samples destined for 
carnosine analysis were snap frozen immediately in liquid nitrogen. All samples were stored 
in a freezer at -80 0C until later analysis.  
4.4.4 Biopsy Analysis 
The MFC analysis took place in Norway (Norwegian School of Sport Sciences) where 
standardised published procedures were followed to identify type I and type II muscle fibre 
counts and their corresponding cross-sectional areas. Muscle biopsies were orientated and cut 
at 8 μm-thickness at −20 °C using a microtome (CM1860, Leica, Germany). The sections were 
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mounted on microscope slides (Superfrost Plus, Thermo Scientific, MA, USA), air-dried, and 
stored at −80 °C. After thawing, sections were blocked in 1% bovine serum albumin (BSA) in 
PBS containing 0.05% Tween 20 (PBS-t; BSA, A4503, Sigma Life Science, St. Louis, MO, 
USA; PBS, 524650, Calbiochem, EMD Millipore, Darmstadt, Germany; Tween 20, 437082Q, 
VWR International, Radnor, PA, USA) for 60 min at room temperature prior to incubating with 
anti-dystrophin (ab15277, AbCam, Cambridge, UK) and anti-myosin heavy chain 1 (BA-D5, 
DSHB, Iowa City, IA, USA; deposited to the DSHB by Schiaffino, S.) antibodies overnight at 
4˚C. After incubating overnight, the sections were washed three times for 10 min in PBS-t and 
incubated with appropriate secondary antibodies (concentration 1:500) (A11005 or A11001, 
Molecular Probes, Life technologies, Carlsbad, CA, USA) for 60 min at room temperature. 
After three 10-min washes in PBS-t, the muscle sections were covered with a coverslip, 
mounted using ProLong Gold Antifade Reagent with DAPI (P36935, Molecular Probes).  
Sections were imaged using a high-resolution camera (DP72, Olympus Corp., Japan) mounted 
on a microscope (BX61, Olympus) with a fluorescence light source (X-Cite, 120PCQ, EXFO 
Photonic Solutions Inc., Mississauga, ON, Canada), using a 4× 0.13 NA air objective (UPlanFL 
N, Olympus) for CSA analyses. Individual muscle fiber 
CSA and fiber type composition were analyzed and 
measurements were calculated using TEMA software 
(Checkvision, Hadsund, Denmark). CSA and fiber type 
composition analysis included 124 (range, 16–287) type 1 
fibers and 180 (range, 23–318) type 2 fibers. Fibers with 
abnormal shape, e.g. longitudinal or oblique, were 
excluded from the CSA analyses. There is no minimum number of fibres for this type of 
analysis, however it has been recommend that around 150 fibres is ideal (Adams, 1968). 
Figure 1 shows a magnified view of how the MFC was determined from each participant. 
Stained fibers showing green were positive for MHC1 whilst the unstained black fibers were 
positive for MHC2. The red lining was positive staining against dystrophin (visualizing the cell 
membrane). 
Fiber-type distribution was studied on immunohistochemical serial preparations using anti-fast 
IIa myosin heavy-chain N2.261 and anti-slow myosin heavy-chain A4.951 monoclonal 
antibodies (concentration 1:500) (Alexis Biochemicals, San Diego, California, USA). The 
Figure 1: Histochemical Staining 
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fibers were designated as Type I and II. For each subject, 100 - 500 fibers were analyzed, and 
each fiber type was expressed as a percentage of the total number counted  
4.4.5 Carnosine Analysis  
Carnosine analysis was completed in the biochemistry laboratory of the School of Human 
Movement and Nutritional Sciences at the University of Queensland. The samples were 
analysed using the method of (Mora, Sentandreu, & Toldra, 2007) with the modifications 
described below. 
Each sample wet weight was measured using electronic scales (AND GRG – 202, Japan). Each 
sample then had 5 times the weight of 10m M Hydrochloric acid (HCl) added to the sample. 
The sample was homogenised using a ‘BeadBug Microtube Homogenizer (Benchmark 
Scientific, Inc Edison, NJ 08818). Each sample used three stainless steel 3mm beads and was 
homogenized for 3 bouts of 20 seconds. Samples were placed on ice before and between bouts 
to maintain temperature. A 20 μl aliquot of the homogenate was removed and placed in the 
freezer for protein analysis.  
The remaining homogenate was then centrifuged at 14 000 rpm for 10 minutes. 70μl of the 
supernatant was removed for HPLC analysis. This was deproteinized using 3 volumes (210 μl) 
of acetonitrile before being mixed (vortex-genie, Scientific Industries) for 10 seconds and then 
resting on ice for 20 minutes. These samples were then centrifuged (Mikro 200, Hettich) again 
at 14 000 rpm for 10 minutes. 
4.4.6 High performance liquid chromatography (HPLC) analysis 
Working standard solutions were prepared over the appropriate concentration range by dilution 
of stock solutions. All stock solutions were stored at -20 °C until use. The carnosine standard 
solutions (Sigma-Aldrich) were set at 0.5 mM, 0.25 mmol and 0.125 mmol through diluting 
stock solutions with distilled water.  
Carnosine was analysed using HPLC (High Pressure Liquid Chromatography) in the 
biochemistry laboratory at the University of Queensland. Twenty microliters of each sample 
was injected into the HPLC system. The chromatographic separation was carried out using a 
Kinetex 5µm HILIC 100A 250 x 4.6mm LC column (Phenomenex, USA) at 27°C. Mobile 
phases consisted of solvent A, containing 0.65 mM ammonium acetate, pH 5.5, in 
water/acetonitrile (25:75), and solvent B, containing 4.55 mM ammonium acetate, pH 5.5, in 
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water/ acetonitrile (70:30). The solvents were filtered through a 0.22 µm membrane filter and 
degassed prior to the analytical run. The separation conditions were a linear gradient from 0 to 
100% of solvent B in 13 min, then held at 100% B for 2 min before returning to 100% A in 3 
min at a flow rate of 1.2 mL/min. The column was equilibrated for 3 min under the initial 
conditions before each injection. The separation was monitored using a diode array detector at 
a wavelength of 214 nm. Peak areas were correlated to compound concentration by 
interpolation in the corresponding calibration curve.  
4.5 Wingate Testing Session  
4.5.1 Anthropometric Measures  
The body mass of each participant was taken without shoes and with exercise attire. Each 
measurement was obtained by the same electronic scales (Avery Weigh-Tronix) for each 
participant. Height was measured using a fixed (Seca 217) stadiometer. 
4.5.2 LODE Protocol Setup 
A LODE cycle ergometer (Excalibur Sport 925900) was used for each Wingate testing session. 
Excalibur Sport LODE software was used to record and analyse Wingate data. Resistance was 
internally loaded in the LODE program. The duration and resistance for each stage of the test 
was pre-set into the program. Resistance was set at 25 Watts (absolute load) for warm up whilst 
a torque factor of 0.7 was used for each Wingate phase. 
 
 
 
 
 
 
Figure 2: Repeated Wingate Protocol 
4.5.3 Bike Setup  
The seat height, handlebar height and distance away was all adjusted for each participant. They 
were instructed to find the most comfortable and powerful position (by changing the seat and 
handlebar positions). This self-selected position was kept constant for all 3 Wingate tests. Live 
data during the Wingate test was not in view of the participants. The warm up, Wingate tests, 
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rest periods and cool down were all programmed into the software and the same protocol was 
used every time.  
4.5.4 Testing Instructions 
The testing protocol was explained to each participant before the commencement of the warm-
up to ensure they were familiar with the test. The following points were repeated and made 
extremely clear to each participant: 
1) “Each Wingate test needs to be a maximal and all-out effort. This means there should be no 
pacing (100% effort from the very first second).  
2) You will start each Wingate in a stationary position with your dominant leg at 90 degrees  
3) You must keep your bottom on the seat at all times during each Wingate  
4) You should not stop the Wingate test until I have instructed you to do so. 
4.5.5 Protocol  
Prior to performing the Wingate tests, each participant filled out an Adult Pre-Exercise Screening 
(APSS) Form to ensure they were safe to conduct the high intensity session. A 24 hour dietary recall 
was also taken to ensure they followed the pre-test requirements. Height and weight were also 
measured and used to make allow relative measurements to be calculated. 
A standardised warm up was prescribed directly before the commencement of each Wingate testing 
session. This was broken up into dynamic stretches (leg swings, waking lunges, bum kicks, high knees, 
body weight squats) and low intensity cycling (60rpms @ 25 W).  
Each participant then had 60 seconds of passive rest before the commencement of the first 30 second 
all out sprint (Wingate). This was then followed by 4 minutes of passive rest. This was then repeated 
2 more times (Wingate + rest). After the 3rd Wingate was completed, a self-directed cool down was 
completed. All participants were provided with standardised encouragement throughout each Wingate 
bout.  
4.6 Data Collection 
4.6.1 Wingate Outcome Measures 
Various performance and fatigue measures were recorded from the LODE cycle ergometer 
(Excalibur Sport 925900) software during the Wingate protocol. The following measures were 
determined; Mean Power (MP), Anaerobic Capacity (AC), Peak Power (PP), Relative Peak 
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Power (RPP), Total Work (TW), Relative Total Work, (RTW), Fatigue Index (FI) and Fatigue 
Profile (FS).  
For the purpose of this study the following definitions of each measure are as follows: Mean 
Power is the average power across the 30 seconds; Anaerobic Capacity is the average power 
divided by body mass; Peak Power is the maximal power; Relative Peak Power is the maximal 
power divided by body mass; Total Work is the average power multiplied by time; Relative 
Total Work is the total work divided by body mass. Fatigue Index was determined by 
calculating the percentage difference between maximal and minimal power. This is measured 
as a percentage.  
(𝑃𝑒𝑎𝑘 𝑃𝑜𝑤𝑒𝑟 − 𝑀𝐼𝑁 𝑃𝑜𝑤𝑒𝑟 𝑂𝑢𝑡𝑝𝑢𝑡)
𝑃𝑒𝑎𝑘 𝑃𝑜𝑤𝑒𝑟 
 𝑋 100 
The Fatigue Profile was determined by dividing the difference between the maximal and 
minimum power output values by the respective amount of time. This was measured in 
Watts/second. 
(𝑃𝑒𝑎𝑘 𝑃𝑜𝑤𝑒𝑟 − 𝑀𝐼𝑁 𝑃𝑜𝑤𝑒𝑟 𝑂𝑢𝑡𝑝𝑢𝑡)
𝑇𝑖𝑚𝑒
  
  
4.6.1 Data Analysis:  
Data were analysed using SPSS statistics software package (version 23.0, SPSS, Inc. Chicago, 
IL). The analysis included the use of standard descriptive statistics, interclass correlation, bland 
Altman plots, Pearson’s correlation coefficients, regression equations or the comparable non-
parametric tests as necessary. Pearson’s Correlation was used to determine the relationships 
between Carnosine and percentage of type II fibres, fibre area and relative fibre area. Mean and 
standard deviations were determined for all muscle tissue and Wingate testing analysis. All 
measures were checked for normality. For all tests, an alpha level 0f 0.05 was set as the standard 
for statistical significance.  
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5.0 Results 
Table 2 shows the results from the Histochemistry and HPLC analysis of the biopsy samples 
(n = 29). Each type of analysis is presented as a mean and standard deviation. All data were 
normally distributed. 
 
Analysis Type Mean SD +/- Range 
Carnosine (mmoL·kg-1dm) 3.58 1.2 2.0 - 7.3 
Type II (%) 60.6 11.9 29.1 – 80.4 
Type I (%) 39.4 11.9 19.6 – 70.9 
Type II CSA (%) 62.8 11.3 36.35 – 83.0 
Type I CSA (%) 42.2 15.3 17.05 – 77.0 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑇𝑦𝑝𝑒 𝐼𝐼 𝐶𝑆𝐴
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑇𝑦𝑝𝑒 𝐼 𝐶𝑆𝐴
 1.23 0.1 0.89 – 1.6 
Table 2. Raw Muscle Biopsy Data   
All 30 muscle samples were successfully analysed for resting carnosine levels. Some of the 
samples however received freezing damage in transit to colleagues in Norway prior to MFC 
analysis. Therefore, 29 samples were successfully analysed for percentage type I and II fibres 
and 24 samples could be analysed for CSA percentage.  
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Figure 3 shows the correlation between resting muscle carnosine level and percentage of 
type II fibres (r = -0.056; p= 0.77; n=29).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was no significant relationship (very weak) between carnosine concentrations and 
percentage of type II fibres. Both variables were obtained from the VL muscle in each 
participant. 
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Figure 4 shows the correlation between resting muscle carnosine level and percentage area of 
type II fibres (r = 0.048; p= 0.838; n= 24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was no significant relationship (very weak) between carnosine and percentage area of 
type II fibres (n=24). Both variables were obtained from the VL muscle in each participant. 
During transit to colleague who conducted the Histochemisty analysis, five muscle samples 
were damaged and were unable to be analysed for CSA.  
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Figure 5 shows the correlation between resting muscle carnosine level and relative fibre size 
(r= 0.07; p= 0.77; n=24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was no significant relationship (very weak) between carnosine concentrations and 
relative fibre (n=24). Both variables were obtained from the VL muscle in each participant. 
During transit to colleague who conducted the Histochemisty analysis, five muscle samples 
were damaged and were unable to be analysed for relative fibre area.  
 
 
 
 
 
 40 
 
Table 3 summarises the performance and fatigue data for all participants (n=26) who 
completed the full protocol. The table shows each Wingate measure as an accumulation over 
the three Wingate sprints. 
Table 3. Performance data from all three Wingate tests 
 
Out of the 30 participants, 27 were able to attend and attempt the Wingate testing session. Only 
one participant was unable to complete the full protocol due to feelings of light-headedness 
and nauseousness. This individual’s data were not included in the analysis; data for the 26 
participants who successfully completed the full study protocol are thus shown. Further details 
and measures from the Wingate tests are and can be found in appendix 2 (Section 9.2).  
 
 
 
 
 
 
 
Wingate Measure Mean SD Range 
Mean Power (W) 632.2 78.2 879.0 – 496.3 
Anaerobic Capacity (W·kg-1BM) 8.52 1.03 6.9 - 10.7   
Peak Power (W) 1163.8 206.7 788.1 - 1,775.2   
Anaerobic Power (W·kg-1BM) 15.6 2.0 11.34 - 18.9   
Total Work (J) 56543.7 6980.1 44,427.5 - 78,507.6 
Relative Total Work (J·kg·bm-1) 224.0 29.9 161.3 - 270.1  
Fatigue Index (%) 37.4 12.8 16.1 - 70.8   
Fatigue Profile (W·sec-1) 36.8 8.9 22.7 - 61.0  
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Figure 6 shows the mean power output profile during each Wingate test (n=26). There was a 
25% reduction in mean power, 24% reduction in anaerobic capacity and a 41% increase in the 
fatigue profile observed between the first and third Wingate tests. 
 
 
 
 
 
 
 
 
 
 
There were a number of significant relationships found within and across variables in each 
Wingate test. The mean power showed significant decreases between each Wingate (W1 – W2; 
p= 0.004, W2 – W3; p= 0.0027) and also throughout the whole repeated protocol (W1 – W3; 
p= <0.0001). 
Anaerobic capacity also showed the same significant differences with (W1 – W2; p= 0.0004, 
W2 – W3; p= 0.0023) whilst also throughout the whole repeated protocol (W1 – W3; p= 
<0.0001).  
Total work also showed significant decreases between each Wingate (W1 – W2; p= 0.005, W2 
– W3; p= 0.0022) and throughout the whole protocol (W1 – W3; p=<0.0001). Relative total 
work showed similar significant decreases with (W1 – W2; p= 0.0119, W2 – W3; p= 0.0014) 
and throughout the whole protocol (W1 – W3; p=<0.0001)  
Peak Power significantly decreased between Wingate tests 1-3 (p=<0.0001) and 2-3 
(p=0.0101). Relative peak power showed the same trend with a significant decreases between 
Wingate tests 1-3 (p=<0.0001) and 2-3 (p=0.0015).  
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Table 4 shows the r and p values of Pearson’s correlations run between resting carnosine levels 
and each Wingate measure within each Wingate bout.  
Pearson’s correlations between Carnosine and Wingate measures from each Wingate 
 
There were no significant relationships between resting carnosine levels and any of the 
performance or fatigue measures in any of the Wingate bouts. 
 
 
 
 
Wingate Measure Wingate 1 Wingate 2 Wingate 3 
Mean Power (W) -0.07437 
(p=0.7124) 
 
0.1700 
(p=0.3966) 
 
0.1553 
(p=0.4487) 
 
Anaerobic Capacity (W/kg.bm) -0.099 
(p=0.6270) 
 
0.2220 
(p=0.2657) 
 
0.1952 
(p=0.3392) 
 
Peak Power (W) -0.1084 
(p=0.5905) 
 
0.1523 
(p=0.4483) 
 
0.1950 
(p=0.3398) 
 
Anaerobic Power (W/kg.bm) -0.08687 
(p=0.6666) 
 
0.2526 
(p=0.2036) 
 
0.2555 
(p=0.2078) 
 
Total Work (J) -0.06892 
(p=0.7327) 
 
0.1680 
(p=0.4022) 
 
0.1535 
(p=0.4540) 
 
Relative Total Work (J/kg.bm) 0.1694 
(p=0.3983) 
 
0.2734 
(p=0.1676) 
 
0.2267 
(p=0.2655) 
 
Fatigue Index (%) -0.1409 
(p=0.4833) 
 
-0.2283 
(p=0.2520) 
 
-0.07584 
(p=0.7127) 
 
Fatigue Profile (W/sec) 0.07965 
(p=0.6929) 
 
0.005933 
(p=0.9766) 
 
0.1980 
(p=0.3322) 
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 Figure 7 shows the relationship between the Fatigue Index in the third Wingate bout and the 
percentage of type II fibres.  
 
 
 
 
 
 
 
 
 
 
 
 
This shows a moderately strong, positive correlation (r= 0.4075; 𝑟2= 0.166; p =0.0432) 
between the percentage of type II and Fatigue Index from the last Wingate bout (n=26).  
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Figure 8 shows the relationship between the Fatigue Index in the third Wingate bout and the 
percentage area of type II fibres.  
 
 
 
 
 
 
 
 
 
 
 
 
 
There was moderately strong and positive correlation (p =0.043; 𝑟2 = 0.199; r = 0.426) between 
the percentage area of type II and Fatigue Index from the last Wingate bout (n=26).  
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Figure 9 shows a breakdown of the last 15 seconds of the 2nd and 3rd Wingate bouts. Each 
graph examines the relationship between Mean Power and Percentage of Type II fibres. The 
‘r’ and ‘p’ values for each correlation is provided on the graphs. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
All six graphs show significant and negative correlations between percentage of type II fibres 
and mean power output. The correlations are stronger on average in the 3rd Wingate test 
compared to the 2nd test. The r and p values show that the correlations are also stronger in the 
25-30 second time period compared with the last 15 seconds.  
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6.0 Discussion  
The present study examined relationships between skeletal muscle fibre composition (MFC), 
carnosine levels and multiple sprint (Wingate) performance. It was hypothesised that 
percentage of type II fibres would be related to carnosine levels and better repeated sprint 
performance. It was also hypothesised that participants with higher carnosine levels would 
perform better (fatigue less) in the latter stages of a 30 second sprint while also in the 
subsequent 2nd and 3rd Wingate tests.   
The primary finding from this study was that resting carnosine levels were not related to 
percentage of type II fibres, percentage area of type II fibres or relative fibre area. In addition, 
resting carnosine levels were not related to any performance or fatigue measures in the repeated 
Wingate protocol. There were however relationships found between fibre type and multiple 
sprint performance; percentage of type II fibres and percentage area of type II fibres were both 
related to power and to fatigue in the latter stages of the protocol.   
6.1 MFC and Resting Carnosine  
The current study found no significant correlations between percentage of type II fibres (r= 
0.056; p= 0.77; n=29), percentage area of type II fibres (r= 0.048; p= 0.83; n=24) or relative 
fibre area (r= 0.065; p= 0.77; n=24) and resting carnosine levels. This finding stands apart from 
the work of Harris et al who reported that type II fibres possess 200% more carnosine than type 
I fibres (Harris et al., 1998).  The current study determined MFC using MHC antibodies, whilst 
Harris and colleagues used ATPase. It remains unclear if the different methods would 
contribute towards the variance.  
However, the present findings agree with the those of (Suzuki et al., 2002) who reported no 
significant relationship between resting carnosine and myosin ATPase determined type II 
fibres. Their investigation determined carnosine and MFC from the VL muscle and provided 
very similar ranges (1.29 – 7.14 mmol; 34.7 – 68.2%) to the current study. Suzuki et al., also 
found a significant correlation (r= 0.65 p= <0.05; n= 11) between resting carnosine and 
percentage of type IIx fibres. It’s unclear whether the current study would have supported or 
disagreed with these findings as the subtype type IIx was not examined. 
An investigation by Baguet, Everaert, Hespel, et al. (2011) found a significantly positive 
correlation (r2 = 0.50; p = 0.009) between percentage area of type II fibres and resting carnosine 
levels. Interestingly this study had very similar ranges of carnosine concentrations (1.82-6.25 
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mM) and percentage type II fibre area (29-62%) to the current study and also those data 
reported by (Suzuki et al., 2002). It is important to note that Baguet, Everaert, Hespel, et al. 
(2011) sampled muscle from the gastrocnemius muscle whilst muscle sampled by Suzuki et al. 
(2002), similar to the current study, was from the VL. It is generally accepted that these two 
muscles are similar in terms of MFC (Elder et al., 1982; Gollnick et al., 1972; Johnson et al., 
1973) however, correlations between MFC and resting carnosine between these muscles are 
yet to be compared. Major differences between the present study and the investigation by 
Baguet et al (2011a) was that they used 1H-MRS to estimate resting carnosine and they had 
relatively low participant numbers (n=12). The same authors published a different paper 
(2011b) which found a significant correlation between 1H-MRS and carnosine measured using 
HPLC (𝑟2= 0.517; p= 0.002). This shows that although there is a significant correlation, the 
correlation coefficient does not account for around half of the variance and could question the 
validity of their carnosine measure.  
An investigation by da Eira Silva et al. (2019) questioned the validity of using magnetic 
resonance spectroscopy (1H-MRS) to determine resting muscle carnosine levels. There was no 
significant relationship found between 1H-MRS determined carnosine and HPLC determine 
carnosine (r=0.27; p=0.38; n=16). The authors noted that various mechanisms such as; 
magnetic interaction with neighbouring nuclei and spin-spin coupling can cause high baseline 
noise (da Eira Silva et al., 2019). Due to the small amplitude of carnosine in 1H-MRS, this noise 
can significantly affect the accuracy and reliability of the reading, particularly with individuals 
who have low levels of carnosine. They concluded by suggesting these methodological issues 
must be considered when using 1H-MRS to interpret resting muscle carnosine values (da Eira 
Silva et al., 2019). 
The present findings in relation to MFC and resting carnosine levels do not deviate much from 
those available in the related literature. The mean and ranges from the current study’s cohort 
data are similar to those of previously published work. However, the methods to determine 
MFC and resting carnosine were different and this could potentially explain disparities.  
6.2 Carnosine and Sprint Performance  
The present study found no significant relationships between carnosine and mean power, 
anaerobic capacity, peak power, relative peak power, total work, relative total work, fatigue 
profile and fatigue index. This does not support the study’s hypothesis and suggests the 
involvement of carnosine as a hydrogen ion buffer did not have a significant effect on either 
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performance or fatigue in this cohort. Though evidence from the available literature is mixed, 
the majority, on balance, show that higher carnosine levels are associated with improved 
Wingate performance (de Salles Painelli et al., 2014; Sale, Saunders, & Harris, 2010; Suzuki 
et al., 2002; Tobias et al., 2013).  
An investigation by Suzuki et al. (2002) reported very similar resting muscle carnosine 
concentrations and sprint performance to those found in the current study. The resting 
carnosine concentrations (3.66 mmol ± 1.87 vs 3.58 mmol ± 1.17) and Mean Power (8.4 W ± 
0.4 vs 8.52 W ± 1.03) from a single Wingate bout were significantly related (r=0.785, p= <0.01; 
n=11) in their study (Suzuki et al., 2002). This may be explained by their participants being all 
untrained; participants in the current study ranged from untrained to trained.  
An abstract published by Lievens (2017), examined performance and fatigue from three 
repeated Wingate tests in pre-selected individuals with extremely high (>0.5 z-score; n=6)  and 
low (>0.5 z-score; n=6) levels of resting muscle carnosine. They reported no significant 
differences in mean power between groups (Lievens, 2017). They did however observe 
significant differences in fatigue within and across each Wingate. The high carnosine group 
presented a higher fatigue index (51% ±5) within each Wingate and across the whole protocol 
(18%±10) when compared to the low carnosine group (36%±5 and 7%±6 respectively). These 
findings differ from the work of Suzuki and colleagues, however their use of 1H-MRS for 
determining muscle carnosine and small participant numbers may explain this.    
It is accepted that carnosine is one of several compounds that contributes to buffering and in 
turn contributes towards anaerobic performance and fatigue (Hill et al., 2007; Sale et al., 2010) 
Many studies have also found that in addition to carnosine, there are numerous other buffering 
mechanisms that can influence sprint and multiple sprint performance. These mechanisms 
include the action of phosphates, proteins and dipeptides in the cytosol after a change in pH 
(Bogdanis, Nevill, Lakomy, & Boobis, 1998; Hill et al., 2007; Sale et al., 2010). Bogdanis et 
al. (1998) suggested that the reduction in intramuscular pH during maximal anaerobic exercise 
does not tend to affect performance or fatigue during a single Wingate bout due to the short 
exercise duration. However, they suggest that the fall in pH significantly affects subsequent 
bouts. This is also supported by their earlier work in 1995 which showed that the fall in pH did 
not have a significant effect on the power output following two Wingate tests (Bogdanis, 
Nevill, Boobis, Lakomy, & Nevill, 1995).  
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An investigation by Baguet, Everaert, De Naeyer, et al. (2011) examined changes in resting 
carnosine levels and buffering capacity after 5 weeks of sprint training. Despite finding no 
significant differences after training, they found a significant correlation (r= 0.343; p= 0.07) 
between resting carnosine levels and overall buffering capacity (Baguet, Everaert, De Naeyer, 
et al., 2011). The authors suggested that carnosine plays a large role in the intracellular 
buffering capacity, however it also suggests that other buffers also affect performance. There 
is still considerable unexplained variance suggesting that factors in addition to resting muscle 
carnosine concentrations influence sprint performance.  
Another potential explanation for the non-significant relationship between carnosine and 
fatigue in the present study may be the range in training status of the participants in the cohort. 
The current study recruited both recreationally active and athletic males. As described earlier 
by (Sale et al., 2010), intracellular buffering capacity is responsive to training and therefore the 
variety in training status may have masked the carnosine buffering contribution.   
Carnosine was also compared to the relative peak power decrease between each Wingate. There 
was a significant and positive relationship (𝑟2= 0.151; p= 0.0497) between carnosine and the 
percentage decrease in relative peak power from Wingate tests 1-2. This decrease ranged from 
31.52% to -7.74%, with a total of seven participants increasing relative peak power in their 2nd 
Wingate. A possible explanation for the increase in relative peak power for the second Wingate 
might be due to the variance in fatigue profiles during the first Wingate. When grouped, these 
seven participants’ fatigue profiles were found to be significantly less (𝑟2= 0.21; p= 0.0184) 
than the remainder of the cohort.  
This relationship also runs true for the seven participants with the highest percentage decrease 
in relative peak power. When compared to the remainder of the cohort, these seven participants 
present significantly (𝑟2= 0.259; p= 0.01) higher fatigue index’s. These findings suggest that 
participants who demonstrate a higher fatigue index are significantly less likely to re-produce 
high relative peak power values for the second Wingate test.  
6.1.1 Carnosine and Fatigue during Latter Stages of the Wingate Tests 
There were no significant relationships found between carnosine and fatigue index or 
performance indicators in the latter stages of any of the Wingate test. There was a common 
trend for the performance to gradually increase and the fatigue profile to gradually decrease 
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with higher levels of resting carnosine. Despite this, no statistical significance was found in the 
15-30, 20-30 or 25-30 second periods in any Wingate bout. 
It was expected that participants with higher carnosine levels would perform better (fatigue 
less) in the latter stages of each Wingate and particularly in the last 5 and 10 seconds; Previous 
research has shown trends in the latter stages of anaerobic exercise and the general role 
carnosine has in the intramuscular buffering capacity. 
Multiple authors have suggested there is a relationship between carnosine and the latter stages 
of maximal sprint exercise (Derave et al., 2007; Suzuki et al., 2002). Suzuki et al. (2002) 
measured resting carnosine levels from muscle biopsy samples and compared these with 
fatigue profiles from one single Wingate test. Positive and significant correlations between 
resting carnosine levels, percentage of type II fibres and mean power output throughout the 30 
seconds and last 10 seconds were found (Suzuki et al., 2002). 
An investigation by Derave et al. (2007) found similar relationships when examining fatigue 
in response to five sets of 30 maximal voluntary isokinetic knee extensions. The individuals 
with higher levels of resting carnosine showed less fatigue in the latter stages of the test which 
resulted in a significant (p= 0.05; n=15) and negative correlation between relative peak power 
and resting carnosine levels (Derave et al., 2007).  
 
An explanation for the different findings in the current study may be due the duration of the 
repeated sprint protocol used. Due to the accumulation of hydrogen ions being the most likely 
mechanism involved, it could be suggested that the present duration of the protocol was simply 
not long enough to induce a significant difference in H+ ion accumulation and consequently a 
significant decrease in performance.  
 
The absence of any relationship between carnosine and the performance or fatigue measures in 
the current study, suggests there are other mechanisms with greater significance as buffers that 
contribute towards repeated high intensity performance. Though it is commonly agreed that 
carnosine is a buffer, the significance this has on the performance of recreationally active 
individuals may be blunted by other mechanisms.  
6.3 MFC and Sprint Performance  
Significant relationships were found between percentage area of type II fibres (r= 0.04; p= 
0.043), percentage of type II fibres (r= 0.408; p =0.0432) and fatigue index during the third 
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Wingate bout. There were no significant relationships between MFC and fatigue in the first 
Wingate, whilst some significant relationships were found in the latter stages of the 2nd sprint. 
These findings are in line with the hypothesis that a higher percentage of type II fibres is 
associated with greater fatigue.  
Individuals with predominantly type II fibres show greater signs of fatigue in the latter stages 
of maximal anaerobic exercise (Bar-Or et al., 1980; Karlsson et al., 1981; P. Tesch & Karlsson, 
1978; Thorstensson & Karlsson, 1976). Despite this consistency, the modes used to elicit 
fatigue vary. Percentage of type II fibres has been correlated with maximal knee extensions, 
40m sprint performance and a single Wingate test.  
Bar-Or and colleagues found similar findings with a single Wingate bout. They found that 56% 
of the variance in power decrease (fatigue) could be explained by relative fibre size. No 
significant correlations were found between percentage area (p=0.38) or percentage of type II 
fibres (p=0.22) with a decrease in power output.  
In contrast to these findings, the current study did not find a relationship between percentage 
of type II fibres (r= 0.3061; p=0.14), percentage area of type II fibres (r= 0.2661; p=0.24) or 
relative fibre area (r= 0.2561; p=0.21) with fatigue during the 1st Wingate test. Although this 
generally agrees with the work of (Bar-Or et al., 1980), the variety in training status of 
participants in the present study may explain the differences. However, a single Wingate sprint 
may not be enough to differentiate between type I and type II fibre dominant individuals; a 
single Wingate sprint may not result in a significant increase in H+ ion production in type II 
dominant individuals to result in a significant decrease in performance.  
Interestingly, the current study found no significant relationships between percentage of type 
II fibres with Peak Power (p=0.8; p=0.54; p=0.48), Relative Peak Power (p=0.9; p=0.74; 
p=0.81), Mean Power (p=0.37; p=0.1; p=0.12), or Relative Mean Power (p=0.7; p=0.38; 
p=0.37) across any of the Wingate tests. It was expected that type II fibres would be related to 
higher peak power during each Wingate. Investigations by (Bar-Or et al., 1980; Suzuki et al., 
2002) agree with this and reported correlations between percentage type II fibres and peak 
power (p= <0.05; p=<0.01) whilst also no significant findings with mean power. Both of these 
papers are very similar to the current study, however the difference in participant training status 
between investigations may in part explain inconsistencies.  
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6.3.1 MFC and Fatigue in Latter Stages  
The percentage of type II fibres was significantly related to the fatigue profile during the last 
15 seconds of the 2nd (r= -0.42; p= 0.036) and 3rd (r= -0.44; p= 0.028) Wingate sprints. These 
relationships become stronger when the last 10 seconds and last 5 seconds in both the 2nd (r= -
0.44; p=0.027 and r=-.045; p=0.02) and 3rd (r= -0.47; p=0.02 and r=-0.046; p=0.02) sprints 
were considered. All six graphs (Figure 6) demonstrate significant and negative correlations 
between percentage of type II fibres and mean power output. It was hypothesised that 
individuals with more type II fibres would fatigue faster in the latter stages of each Wingate 
bout. This was based on the idea that type II fibres at a cellular level fatigue at a significantly 
faster rate compared with type I.  
There are various mechanisms that might explain why individuals with predominantly type II 
fibres showed greater fatigue in latter stages of maximal anaerobic exercise. One reason might 
be the production and accumulation of lactate in the exercising muscles. It’s been shown that 
high levels of H+ production in maximal anaerobic exercise has been correlated with higher 
performance (Thorstensson & Karlsson, 1976). Although this is the case, a long duration of 
maximal exercise will end up accumulating these H+ ions and consequently decreasing 
performance (Thorstensson & Karlsson, 1976). This premise supports the current findings as 
the significant differences in MFC relate fatigue is exclusive to the latter stages of the protocol.  
It could be assumed that the accumulation of H+ ions in type II dominant individuals became 
a significant factor in performance in the last Wingate and latter stages of the 2nd, due to a 
higher production rate. It seems reasonable to propose that the contribution of H+ ions as a 
result of a high proportion of type II fibres would be partially responsible for the fatiguing 
during anaerobic endurance capacity.  
6.4 Wingate Performance and Fatigue  
The mean cohort fatigue index showed a significant increase (p=0.0048) between the first and 
last Wingate sprints. The mean fatigue profile showed small decreases, but there were no 
significant differences across any of the Wingate tests. The lack of significant differences 
between Wingate trials for fatigue profile, may be explained by the significant decreases in 
peak power across each Wingate. Due to the reduction in peak power in Wingate sprints 1 and 
2, there will be a small decrease in power output even if there is a higher percentage of fatigue. 
This is also confirmed by the significant correlation (r= 0.75; p=< 0.0001) shown in Appendix 
4 (Section 9.4). This shows that participants who recorded a high original peak power, also 
 53 
 
fatigued the greatest during the sprint. This trend also stays consistent when compared with the 
fatigue index in the last 10 seconds. There was a significant and positive correlation (r= 0.61; 
p= 0.001) between peak power and the fatigue profile from the last 10 seconds.  
The performance data from the current study is consistent with studies that have used 
recreationally active males of a similar demographic  (Forbes, Candow, Little, Magnus, & 
Chilibeck, 2007; Greer, McLean, & Graham, 1998; Inbar et al., 1981; Watt, Hopkins, & Snow, 
2002). As seen in Appendix 1, there were significant decreases in peak power, mean power, 
anaerobic capacity, anaerobic power and total work across each Wingate (Section 9.1). There 
were also significant increases in the fatigue index and slope across each Wingate test. All of 
the present cohort sprint data are consistent with those from other studies that have examined 
the same variables during a 3 x Wingate protocol with 4 minute rest periods (Greer et al., 1998; 
Inbar et al., 1981; Lievens, 2017; McCartney et al., 1986; Spriet, Lindinger, McKelvie, 
Heigenhauser, & Jones, 1989; Suzuki et al., 2002). 
6.5 Practical Applications  
The current study has reported that MFC influences multiple sprint performance, particularly 
in the latter stages of exercise. Strength and conditioning coaches and high performance staff 
can use this knowledge to make subtle changes to training programs for individuals who may 
possess high percentages of a certain fibre type. It could be proposed that type II dominant 
athletes may need longer rest periods and shorter exercise duration when prescribing anaerobic 
exercise to account for the likelihood of high levels of fatigue in the latter stages.  
The lack of variance reported in the 1st Wingate bout can also show practitioners that a single 
Wingate test may not provide an accurate understanding and representation of maximal 
anaerobic performance and fatigue. It would be suggested that if coaching staff require a 
comprehensive understanding of how an individual performs and fatigues during maximal 
anaerobic exercise, a repeated Wingate protocol similar to this study should be implemented.  
The performance in the latter stages of this protocol can also provide practitioners with an 
estimation of an individual’s MFC. The significant correlation with type II fibres and fatigue 
in last 15 seconds of the 2nd and the whole 3rd Wingate bout, suggested that individuals who 
show grater signs of fatigue may also present with a higher percentage of type II fibres. 
Therefore, examining performance in these latter stages (observing or using a regression 
model) may assist in the estimation of MFC for athletic individuals.  
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Various recommendations can be made for individuals who show greater signs of fatigue in 
the latter stages of anaerobic exercise.  It may be beneficial to extend rest periods between sets 
in resistance training and anaerobic conditioning drills. Due to the higher chance of H+ ion 
accumulation, these individuals may require longer rest periods to ensure performance on the 
subsequent sets are of quality.  To optimise performance, it also may be beneficial for these 
individuals to limit maximal anaerobic bouts of exercise to short durations (less than 20 
seconds). If longer durations of maximal effort are required during competition, it would be 
recommended that extended rest is taken directly after.  
6.6 Limitations and Future Directions   
A limitation in any study that involves muscle biopsies is the size of the sample collected and 
method of analysis. The muscle sample used to determine the MFC of the VL muscle in the 
present study was less than 1% of the entire muscle. The muscle biopsy procedure is commonly 
accepted as the gold standard procedure when it comes to MFC, however the sample does not 
necessarily represent the whole muscle belly. It would be recommended that multiple samples 
from different portions of the VL muscle are taken to ensure there is no grouping or localised 
fibre composition effects on the reading. 
Another possible limitation is the lack of a familiarisation session for the Wingate testing. 
Completing a single Wingate bout prior to the actual testing protocol could allow the 
participant to become familiar with the maximal nature of the task. This would mentally 
prepare each individual for the task, whilst also giving the researcher information to see if 
pacing is present. Although it was made extremely clear prior to the test that is was to be an 
all-out, maximal effort, the demanding nature of the test suggests a cognitive/mental 
component may have a subtle impact on the fatigue profile.  
It is recommended that future research should focus on identifying the influence of high 
percentages of MFC or extreme levels of muscle carnosine on maximal anaerobic performance. 
Although the current study had a good range of MFC and resting muscle carnosine values, it 
would be of benefit to examine a large number of individuals who possess high percentages of 
either type I or II fibres or particularly high and low carnosine levels. This could further develop 
the understanding of anaerobic performance in athletic populations and could warrant changes 
in the way coaching staff individualise exercise programs.  
Given that muscle carnosine may not play a significant role in performance during maximal 
anaerobic exercise, the use of supplements aimed at increasing resting carnosine concentrations 
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(eg. beta-alanine) is questionable; further research could include supplementation within an 
experiment that includes the same procedures as those used in the present study. 
7.0 Conclusions 
The present investigation found no significant relationships between MFC and resting muscle 
carnosine levels. Contrary to the hypothesis, there were no significant relationships between 
resting carnosine levels and any performance or fatigue measures in the repeated Wingate 
protocol.  
There were however relationships found between fibre type and multiple sprint performance; 
percentage of type II fibres and percentage area of type II fibres were both related to an increase 
in fatigue during the latter stages of the protocol. This may be explained by the increased 
production of H+ ions and the inability to regulate them in the latter stages of the protocol.  
This study has furthered the current research and highlighted the relationships and roles of 
MFC and carnosine in maximal anaerobic exercise. In summary, this investigation showed no 
relationship between MFC and resting muscle carnosine levels, whilst also demonstrating that 
individuals with a relatively higher percentage of type II fibres may show greater levels of 
fatigue in the latter stages of maximal anaerobic exercise.      
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9.0 Appendices   
 
9.1 Wingate Mean Cohort Data.  
 
 
 
 
 
 
 
 
 
 
 
 
The mean and standard deviations for each measure are shown for each Wingate bout. Total 
Work and Relative Total Work both significantly decrease across each Wingate test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Mean and Relative Mean Power both significantly decrease across each Wingate test.  
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Peak Power and Anaerobic Power both significantly decrease across each Wingate test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fatigue Index shows a significant increase from the first to third Wingate tests. Fatigue Profile 
did not show any significant changes throughout the Repeated Wingate Protocol.  
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9.2 Mean Wingate Performance Measures  
 
 
Table 5 describes the Wingate measures exclusively from the first Wingate test (n=27). This 
shows the mean and standard deviations for each Wingate measure.   
 
 
Table 6 describes the Wingate measures exclusively from the second Wingate test (n=27). This 
shows the mean and standard deviations for each Wingate measure. 
 
 
Table 5. Wingate 1 
Wingate Measure Mean SD Range 
Mean Power 725.12 84.23 1014.96- 589.25 
Anaerobic Capacity 9.75 0.8 10.83 - 8.06 
Peak Power 1303.25 249.6 1849.46 - 796.08 
Anaerobic Power 17.42 2.42 22.48 - 11.50   
Total Work 21602.73 2520.51 30259.88 - 17529.56 
Relative Total Work 255.74 22.33 291.46 - 217.17 
Fatigue Index 30.51 10.81 57.30 - 9.81 
Fatigue Slope 38.85 10.2 61.21 - 18.50 
Table 6. Wingate 2 
Wingate Measure Mean SD Range 
Mean Power 627.27 77.63 848.24 - 475.49 
Anaerobic Capacity 8.46 1.1 10.69 - 6.68 
Peak Power 1192.55 240.92 1910.13 - 808.41 
Anaerobic Power 15.94 2.24 19.48 - 11.68 
Total Work 18735.69 2291.64 25220.65 - 14263.64 
Relative Total Work 226.41 29.32 279.40 - 154.65 
Fatigue Index 38.72 14.7 69.36 - 14.04 
Fatigue Slope 37.88 10.6 67.35 - 21.71 
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Table 7 describes the Wingate measures exclusively from the third Wingate test (n=27). This 
shows the mean and standard deviations for each Wingate measure. 
 
9.3 Mean Wingate Fatigue Graphs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 shows the mean power output profile of the first Wingate test. Mean power 725.12 
± 78.2, peak power 1163.81 ± 206.71 and fatigue index 30.51 ± 10.81 
Table 7. Wingate 3 
Wingate Measure Mean SD Range 
Mean Power 544.09 98.61 773.66 - 346.92 
Anaerobic Capacity 7.35 1.45 10.47 - 4.84 
Peak Power 995.62 218.25 1565.89 - 513.13 
Anaerobic Power 13.41 2.84 18.26 - 7.33 
Total Work 16205.28 2943.23 23027.13 - 10325.60 
Relative Total Work 190.01 50.12 257.95 - 80.23 
Fatigue Index 42.86 15.15 85.59 - 20.24 
Fatigue Slope 33.57 8.03 54.54 - 23.08 
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Figure 12 shows the mean power output profile of the second Wingate test. Mean power 
627.27 ± 77.63, peak power 1192.55 ± 240.92 and fatigue index 38.72 ± 14.7. 
 
 
 
 
 
 
 
 
 
 
Figure 13 shows the mean power output profile of the third Wingate test. Mean power 544.09 
± 98.61, peak power 995.62 ± 218.25 and fatigue index 42.86 ± 15.15. 
 67 
 
500 1000 1500 2000
0
10
20
30
20 - 30s
Peak Power
F
a
ti
g
u
e
 (
W
/s
e
c
)
1000 1500 2000
0
5
10
15
20
Peak Power (W)
F
a
ti
g
u
e
 (
W
/s
e
c
)
Wingate 1
9.4 Fatigue Profile and Peak Power   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 shows a significant and positive and significant correlation (r= 0.75; p=< 0.0001) 
between the fatigue profile from the first Wingate (30 seconds) and peak power.  
 
 
 
 
 
 
 
 
 
Figure 15 shows a significant and positive and significant correlation (r= 0.61; p= 0.001) 
between the fatigue profile from the last 10 seconds of the first Wingate and peak power. 
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10.0 Conference Abstracts 
10.1 ASCA International Conference Abstract  
The Relationship between Muscle Fibre Composition and Fatigues During Maximal 
Anaerobic Exercise? 
Rick A. 𝐃𝐚𝐧𝐧𝟏, Vincent G 𝐊𝐞𝐥𝐥𝐲𝟐, David G 𝐉𝐞𝐧𝐤𝐢𝐧𝐬𝟏 
University1 of Queensland Queensland2 University of Technology 
Email: Rick.dann@uqconnect.edu.au 
BLUF: Individuals with predominantly type II muscle fibres may show greater reductions in 
mean power and a greater degree of fatigue in the latter stages of maximal anaerobic exercise. 
INTRODUCTION: Muscle Fibre Composition (MFC) is an important characteristic in 
determining how a muscle performs and fatigues. It’s well documented that at a cellular 
level; type I muscle fibres produce less force and fatigue less whilst type II fibres produce 
greater force and fatigue more quickly. However, the significance of possessing different 
proportions of these fibres and its effect on maximal anaerobic performance and fatigue is 
still uncertain. The current literature is limited by the use of single Wingate protocols to 
induce fatigue. Therefore the aim of this study was to examine the relationships between 
muscle biopsy determined MFC and various performance and fatigue measures derived from 
three repeated Wingate bouts. 
METHODS: Twenty-six healthy males (age: 25 ± 4 y; weight 74.0 ± 9.8kgs; height: 1.75 ± 
0.11m) were recruited for this study. Each participant had a muscle biopsy from the vastus 
lateralis muscle and completed three Wingate (30 second sprints) on a LODE cycle 
ergometer, with 3 minutes of passive recovery between trials. Mean Power (MP), anaerobic 
capacity (AC), peak power (PP), total work (TW) and a fatigue index (FI) was calculated for 
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each Wingate. The analysis included standard descriptive statistics, Pearson correlation and 
linear regressions. 
RESULTS: The percentage of type II fibres was significantly correlated with a decrease in 
MP throughout the last 15 seconds of the 2nd (r=-0.4201, p=0.0366) and 3rd (r=-0.4388; 
p=0.0282) Wingate bouts. These correlations were also found within each 5 second period 
(15-20, 20-25, 25-30sec) from both of the last two Wingate test. There was also a significant 
correlation (r=0.4075; p=0.0432) found between the percentage type II fibres and the fatigue 
profile from the 3rd Wingate bout. No significance was found between type II percentage and 
MP, AC, PP, TW or FI in the first Wingate. 
DISCUSSION: The available evidence suggests the rate at which H+ ions are produced in 
muscles during high intensity exercise is related to the type of muscle fibres contributing 
towards the movement. It’s also commonly accepted that individuals who have the capacity 
to regulate H+ ions (increased buffer capacity) and/or produce less of them during intense 
exercise may be able to delay fatigue and potentially improve sprint and high intensity 
exercise performance. Therefore the decrease in MP and increase in FI with type II dominant 
individuals may be explained by the increased production of H+ ions and the inability to 
regulate them. 
PRACTICAL APPLICATIONS: The use of a single Wingate test may not provide an 
accurate understanding on how an individual performs and fatigues during maximal 
anaerobic exercise. Based off performance in the latter stages of this protocol, practitioners 
can estimate whether an individual may possess an increased percentage of type I or II fibres. 
From this information, subtle changes in rest periods, training volume and intensities could 
be made to individualise strength and conditioning programs. 
 70 
 
10.1.1 ASCA International Conference Poster  
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10.2 UQ HMNS 2019 Conference Abstract 
Does Muscle Fibre Composition effect Performance and Fatigue during Maximal 
Anaerobic Exercise? 
Rick A. 𝐃𝐚𝐧𝐧𝟏, Vincent G 𝐊𝐞𝐥𝐥𝐲𝟐, David G 𝐉𝐞𝐧𝐤𝐢𝐧𝐬𝟏 
University1 of Queensland Queensland2 University of Technology 
Presenter: Ricky Dann 
Email: Rick.dann@uqconnect.edu.au 
Title: Does Muscle Fibre Composition effect Performance and Fatigue during Maximal 
Anaerobic Exercise? 
INTRODUCTION: Muscle Fibre Composition (MFC) is commonly accepted as an important 
factor in determining how a muscle performs and fatigues. However, the significance of 
possessing different proportions of type I and II fibres and its effect on maximal anaerobic 
performance and fatigue is still uncertain. Therefore the aim of this study was to examine the 
relationships between MFC and various performance and fatigue measures derived from 
three repeated Wingate bouts. METHODS: Twenty-six healthy males (age: 25 ± 4 years) 
were recruited for this study. Each participant had a muscle biopsy from the vastus lateralis 
muscle and completed three Wingates on a LODE cycle ergometer, with 3 minutes of passive 
recovery between trials. Mean Power (MP), anaerobic capacity (AC), peak power (PP), total 
work (TW) and a fatigue index (FI) was calculated for each Wingate. RESULTS: The 
percentage of type II fibres was significantly correlated with a decrease in MP throughout the 
last 15 seconds of the 2nd (r=-0.4201, p=0.0366) and 3rd (r=-0.4388; p=0.0282) Wingate 
bouts. There was also a significant correlation (r=0.4075; p=0.0432) between the percentage 
of type II fibres and fatigue profile from the 3rd Wingate bout. CONCLUSION: This 
suggests that individuals with predominantly type II fibres may produce more H+ ions 
resulting in an accumulation of lactate in the latter stages of anaerobic exercise. From this 
information, general MFC estimations can be made, whilst also subtle changes to strength 
and conditioning programs for optimising performance and recovery. 
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10.3 UQ HMNS 2018 Conference Abstract 
 
An Innovate Insight into Muscle Fibre Composition Prediction 
Rick A. 𝐃𝐚𝐧𝐧𝟏, Vincent G 𝐊𝐞𝐥𝐥𝐲𝟐, David G 𝐉𝐞𝐧𝐤𝐢𝐧𝐬𝟏 
University1 of Queensland Queensland2 University of Technology 
Email: Rick.dann@uqconnect.edu.au 
Through the knowledge of an athletes muscle fibre composition (MFC), high performance staff 
can implement more effective training programs, individualise training stimuli and possibly 
assist in reducing the likelihood of musculoskeletal injury. The current gold standard and most 
accepted method however (muscle biopsy), is invasive and not practical for elite athletes. The 
aim of this thesis is to i) address and critique alternate (non-invasive) methods which can 
predict muscle fibre composition ii) explore the validity of a new non-invasive method (MRI) 
which has shown promising results in previous research. A literature review titled ‘Determining 
Muscle Fibre Type: An Updated Review’ explores the current attempts in the literature to 
predict muscle fibre composition and include; MRI, Tensiomyography (TMG), strength testing 
and exercise protocols. Part two of this investigation will examine the validity of the MRI 
method through a comparison study with the traditional biopsy method. The updated review 
found that MRI is the most valid method whilst strength testing and repetition max based 
protocols proved less reliable but more cost effective. Based off previous research, it’s expected 
that the second study in this thesis will show an agreement between the two methods (MRI and 
traditional biopsy) when predicting muscle fibre composition. The analysis for each MF 
prediction method will serve as an important tool when taking an innovative approach to 
developing athletes’ exercise programs. The validation of the MRI method will promote the 
integration of an evidence based, non-invasive and practical approach to MF prediction within 
high performance sport. 
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